FDA authorized InBios COVID-19 over-the-counter antigen test
On Nov. 22, 2021, the U.S. Food and Drug Administration (FDA) authorized another over-the-counter (OTC) COVID-19 antigen test. The…
On Nov. 22, 2021, the U.S. Food and Drug Administration (FDA) authorized another over-the-counter (OTC) COVID-19 antigen test. The…
On Nov. 22, 2021, Tonix Pharmaceuticals announced the publication of ‘Sangivamycin is highly effective against SARS-CoV-2 in vitro…
On Nov. 22, 2021, Pfizer announced topline results from a longer-term analysis of the safety and efficacy of…
On Nov. 21, 2021, Gavi, the Vaccine Alliance, announced that India has completed the national introduction of pneumococcal…
On Nov. 19, 2021, the U.S. Food and Drug Administration (FDA) announced that it had extended the emergency…
On Nov. 19, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had expanded…
On Nov. 18, 2021, Pfizer announced an agreement with the U.S. government to supply 10 million treatment courses…
On Nov. 17, 2021, Jubilant HollisterStier broke ground for our $285 million Spokane facility expansion. This expansion is…
On Nov. 17, 2021, Pacific Northwest National Laboratory (PNNL) announced researchers had compiled the most comprehensive road map…
On Nov. 17, 2021, Novavax and and Serum Institute of India announced that the Philippine Food and Drug…
On Nov. 17, 2021, scientists at the Centers for Disease Control and Prevention (CDC) announced they were collaborating…
On Nov. 17, 2021, Zosano Pharma announced that the Philippine Food and Drug Administration had granted emergency use…
On Nov. 17, 2021, GlaxoSmithKline and Vir Biotechnology announced U.S. government contracts totalling approximately $1 billion (USD) to…
On Nov. 17, 2021, Novavax announced that the European Medicines Agency (EMA) had begun its evaluation of an…
On Nov. 16, 2021, the University of Oxfordメs and AstraZeneca announced that two billion doses of the ChAdOx1…
On Nov. 16, 2021, Pfizer and the Medicines Patent Pool (MPP), a United Nations-backed public health organization working…
On Nov. 16, 2021, Illumina and Genetic Alliance announced the creation of the iHope Genetic Health program aimed…
On Nov. 16, 2021, Pfizer announced it had submitted an Emergency Use Authorization (EUA) of its investigational oral…
On Nov. 16, 2021, an agreement was announced that enabled the European Union and European Economic Area countries…
On Nov. 15, 2021, Novavax and SK bioscience announced submission of a Biologics License Application (BLA) for Novavax’…
On Nov. 15, 2021, a large, long-term study of the impacts of COVID-19 on children announced it had…
On Nov. 15, 2021, Moderna confirmed that Health Canada had authorized the use of a booster dose of…
On Nov. 15, 2021, AstraZeneca reported that 2 billion doses of the COVID-19 vaccine had been released for…
On Nov. 14, 2021, the Calgary city council voted to reinstate fluoridation in Calgary’s waters. The count was…
On Nov. 12, 2021, with COVID-19 infections surging worldwide, a united group of 18 companies representing a large…
On Nov. 12, 2021, Innovation Pharma announced the Company was conducting full data analysis of the Phase 2…
On Nov. 12, 2021, GlaxoSmithKline and Vir Biotechnology announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase…
On Nov. 12, 2021, Lincoln Children’s Zoo announced on Facebook that their three snow leopards: Ranney, Everest and…
On Nov. 11, 2021, Zipline, Pfizer and BioNTech announced that Zipline had successfully completed the first long-range drone…
On Nov. 11, 2021, Innovation Pharma reported topline results from the Companyメs Phase 2 clinical trial of Brilacidin…